Tokai Pharmaceuticals Company Profile (NASDAQ:TKAI)

Analyst Ratings

Consensus Ratings for Tokai Pharmaceuticals (NASDAQ:TKAI) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $19.25 (1,452.42% upside)

Analysts' Ratings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Bank of America Corp.DowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016BMO Capital MarketsDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Oppenheimer Holdings Inc.Reiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Jefferies GroupInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/10/2016        
5/10/2016Q1($0.50)($0.51)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q4($0.47)($0.49)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q3($0.53)($0.53)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.50)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2015Q115($0.31)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015($0.40)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014($0.42)($2.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tokai Pharmaceuticals (NASDAQ:TKAI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20161($0.63)($0.63)($0.63)
Q3 20161($0.68)($0.68)($0.68)
Q4 20161($0.73)($0.73)($0.73)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tokai Pharmaceuticals (NASDAQ:TKAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/15/2016Stephen Jr. BuckleyDirectorBuy8,000$5.74$45,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Stephen Jr. BuckleyDirectorBuy3,000$11.25$33,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015John S. McbrideCOOSell13,500$14.01$189,135.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Lee KalowskiCFOSell4,668$13.13$61,290.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Lee KalowskiCFOSell2,158$12.96$27,967.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Bioventures Ltd NovartisMajor ShareholderSell3,566$14.26$50,851.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Bioventures Ltd NovartisMajor ShareholderSell27,861$14.41$401,477.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Bioventures Ltd NovartisMajor ShareholderSell20,611$14.20$292,676.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Jodie Pope MorrisonCEOSell16,000$13.77$220,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2015John S McbrideCOOSell9,000$14.01$126,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015John S McbrideCOOSell6,700$14.00$93,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015John S McbrideCOOSell2,000$14.02$28,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Bioventures Ltd NovartisMajor ShareholderSell1,120$14.27$15,982.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2015Bioventures Ltd NovartisMajor ShareholderSell27,875$14.20$395,825.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2015Lee KalowskiCFOSell4,567$13.00$59,371.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Lee KalowskiCFOSell2,258$11.45$25,854.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Bioventures Ltd NovartisMajor ShareholderSell49,141$14.50$712,544.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Apple Tree Partners Ii - AnnexDirectorBuy237,500$15.00$3,562,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Bioventures Ltd NovartisMajor ShareholderBuy325,000$15.00$4,875,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateHeadline
07/28/16 10:15 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Tokai Pharmaceuticals, Inc. and Certain Officers and Directors -- TKAI - [Business Wire] - Levi & Korsinsky, LLP announces that it has commenced an investigation of Tokai Pharmaceuticals, Inc. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
07/27/16 07:13 PMWhat’s Next For Tokai Pharmaceuticals Inc (NASDAQ:TKAI)?
07/27/16 06:49 PMIMPORTANT INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against Tokai Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that it is investigating Tokai Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
07/27/16 09:55 AMInvestigation of Tokai Pharmaceuticals Announced by Holzer & Holzer LLC
07/27/16 09:55 AMTokai (TKAI) Plunges after Halting Prostate Cancer Trial
07/27/16 09:15 AMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tokai Pharmaceuticals, Inc. (TKAI) - [PR Newswire] - NEW YORK, July 27, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Tokai Pharmaceuticals, ...
07/26/16 07:17 PM15 Biggest Mid-Day Losers For Tuesday - Benzinga
07/26/16 03:02 PMTOKAI PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events -
07/26/16 12:59 PMSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Tokai Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that it is investigating Tokai Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
07/26/16 10:46 AMINVESTOR ALERT: Investigation of Tokai Pharmaceuticals Announced by Holzer & Holzer LLC - [Business Wire] - Holzer & Holzer, LLC is investigating whether statements made by Tokai Pharmaceuticals, Inc. regarding its business and operations complied with federal securities laws.
07/26/16 10:19 AMTokai Pharma (TKAI) to Cease ARMOR3-SV Clinical Trial
07/26/16 09:07 AMTokai's shares tumble as it halts prostate-cancer drug trial -
07/26/16 08:30 AMTokai Pharmaceuticals stock plummets after drug trial discontinued -
07/26/16 06:08 AMTokai Pharmaceuticals Announces Clinical Update - [at noodls] - Company to Discontinue Phase 3 ARMOR3-SV Trial of Galeterone in AR-V7 Positive mCRPC Tokai to Host Conference Call Today at 8:30 AM E.T. ... This is an abstract of the original noodl. To continue reading ...
07/22/16 06:38 PMTokai Pharmaceuticals Inc Can't Burn Your Long Portfolio. Has Another Strong Session - Press Telegraph
07/22/16 06:38 PMTokai Pharmaceuticals Incorporated (NASDAQ:TKAI) Sellers Covered 2.02% of Their Shorts - Consumer Eagle
07/21/16 07:08 PMTokai Pharmaceuticals, Inc. (NASDAQ:TKAI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 07:51 PMEarnings Focus and Crowd Sourced Sentiment Review for Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - TGP
07/20/16 07:51 PMEquity Roundup: Stock Performance Focus on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Press Telegraph
07/20/16 07:51 PMTokai Pharmaceuticals Inc Stock Momentum Hits Extreme Weakness - CML News
07/20/16 07:51 PMWhat's Propelling Tokai Pharmaceuticals Inc to Decrease? The Stock Formed a Bearish Multiple Bottom - Consumer Eagle
07/18/16 09:05 AMTokai Pharmaceuticals Incorporated (NASDAQ:TKAI) Shorted Shares Decreased By 3.52% - Consumer Eagle
07/17/16 06:06 PMShares Moving Down on the Week: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Engelwood Daily
07/17/16 06:06 PMNext Weeks Broker Price Targets For Tokai Pharmaceuticals, Inc. (TKAI) - Fiscal Standard
07/16/16 06:06 PMTokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/16/16 06:06 PMShares Experiencing a Downtrend: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - TGP
07/16/16 06:06 PMHow Many Tokai Pharmaceuticals Inc (NASDAQ:TKAI)'s Analysts Are Bullish? - Consumer Eagle
07/13/16 07:08 PMInvestor Update - Shares Lower in Session: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Telanagana Press
07/13/16 07:08 PMShare Volatility Watch for: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Engelwood Daily
07/13/16 09:41 AMTokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 09:41 AMIs Major Move Coming For Tokai Pharmaceuticals Inc After This Multiple Bottom? - Consumer Eagle
07/13/16 09:41 AMTokai Pharmaceuticals Inc (NASDAQ:TKAI) Institutional Investors Quarterly Sentiment - Press Telegraph
07/09/16 06:04 PMTokai Pharmaceuticals Incorporated (NASDAQ:TKAI) Short Interest Decreased By 3.52% - Press Telegraph
07/07/16 06:53 PMTokai Pharmaceuticals, Inc. Stock Momentum at Critical Inflection Point - CML News
07/07/16 06:53 PMCan Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Improve on the Earnings Front? - Engelwood Daily
07/07/16 09:33 AMCompany Stock Focus for Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI): Which Way Will Shares Head? - Press Telegraph
07/07/16 09:33 AMInsiders Increasing Positions in: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Press Telegraph
07/05/16 06:27 PMBroker Outlook For The Week Ahead Tokai Pharmaceuticals, Inc. (TKAI) - Fiscal Standard
07/03/16 08:43 AMTracking Stock Volatility for: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Engelwood Daily
07/03/16 08:43 AMTokai Pharmaceuticals Incorporated (NASDAQ:TKAI) Shorts Decreased by 3.52% After Short Covering - Press Telegraph
07/03/16 08:43 AMAre Analysts Bullish Tokai Pharmaceuticals Inc (NASDAQ:TKAI) After Last Week? - Press Telegraph
06/24/16 09:22 AMTokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 09:22 AMTokai Pharmaceuticals, Inc. (TKAI) Current Analyst Ratings - Fiscal Standard
06/22/16 06:45 PMTokai Pharmaceuticals, Inc. (NasdaqGM:TKAI) Stock Momentum Hits Weakness - CML News
06/21/16 06:18 PMThis Weeks Broker Views For Tokai Pharmaceuticals, Inc. (TKAI) - Fiscal Standard
06/16/16 06:02 AMTOKAI PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/06/16 01:30 PMTokai Pharmaceuticals, Inc. :TKAI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 -
06/05/16 09:31 AMTokai Pharmaceuticals Incorporated (NASDAQ:TKAI) Short Interest Decreased By 1.04% - HNN
06/03/16 07:31 PMStock Review and Earnings Check on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - HNN
06/02/16 07:19 PMTokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Stock Update & Estimates - Stock Tick Tock - Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) to post earnings of $-0.54 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be ...and more »

Social

About Tokai Pharmaceuticals

Tokai Pharmaceuticals logoTokai Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of prostate cancer and other hormonally-driven diseases. The Company's lead drug candidate, galeterone, is an oral small molecule that utilizes the mechanistic pathways of second-generation androgen signaling inhibitors, while also introducing a third mechanism-androgen receptor degradation. The Company develops galeterone for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC. The Company is conducting a pivotal Phase III clinical trial comparing galeterone to Xtandi (enzalutamide) in approximately 148 treatment-naive mCRPC patients whose prostate tumors express the AR-V7 splice variant. The Company refers clinical trial as ARMOR3-SV, a precision-medicine based pivotal clinical trial in prostate cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TKAI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.24
  • 50 Day Moving Average: $5.40
  • 200 Day Moving Average: $6.22
  • P/E Ratio: N/A
  • P/E Growth: 0.01
  • Market Cap: $27.61M
  • Beta: 1.86
  • Current Year EPS Consensus Estimate: $-2.03 EPS
  • Next Year EPS Consensus Estimate: $-1.98 EPS
Additional Links:
Tokai Pharmaceuticals (NASDAQ:TKAI) Chart for Friday, July, 29, 2016